Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
177
USD
|
+1.28%
|
|
+4.63%
|
-20.09%
|
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Low profitability weakens the company.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
|
1st Jan change
|
Capi.
|
Investor Rating
|
ESG Refinitiv
|
---|
| -20.09% | 26.53B | | C | | +1.38% | 9.32B | |
-
| | -25.68% | 729M | |
-
| | -1.92% | 479M |
-
|
-
| | -9.71% | 448M | |
-
| | -9.63% | 273M |
-
|
-
| | -28.88% | 210M |
-
|
-
| | -42.63% | 189M |
-
|
-
| | -6.34% | 152M | |
-
| | -38.99% | 149M |
-
|
-
|
4 months Revenue revision
Divergence of analysts' opinions
Divergence of Target Price
|